This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jyothirmayi, G. N. Articles by Reddi, A. S. Search for Related Content PubMed PubMed Citation Articles by Jyothirmayi, G. N. Articles by Reddi, A. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DOXAZOSIN MESYLATE

(Hypertension. 1996;27:1108-1114.)
© 1996 American Heart Association, Inc.

Articles

Doxazosin Prevents Proteinuria and Glomerular Loss of Heparan Sulfate in Diabetic Rats

Garikiparthy N. Jyothirmayi; Indira Alluru; Alluru S. Reddi

From the Department of Medicine, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark.

Abstract We examined whether blood pressure reduction or good glycemic control equally lower albuminuria by preventing glomerular loss of heparan sulfate and progression of glomerulosclerosis in streptozotocin-induced diabetic rats. We used doxazosin, an ₁-adrenergic blocker, to lower systemic blood pressure, and good glycemic control was achieved by insulin treatment. Rats were killed after 20 weeks of treatment. Doxazosin significantly lowered systolic pressure in diabetic rats; however, it had no effect in normal rats. Good glycemic control also lowered systolic pressure. In diabetic rats with good glycemic control, doxazosin had an additive effect on blood pressure. Glomerular heparan sulfate synthesis was significantly lower and urinary albumin excretion higher in diabetic than in normal rats. Both doxazosin treatment and good glycemic control normalized these abnormalities in diabetic rats. Insulin normalized plasma glucose and glycosylated HbA₁ concentrations in diabetic rats, as did doxazosin. Significant increases in mesangial area and glomerulosclerosis were observed in diabetic rats. Only good glycemic control normalized these pathological changes in all diabetic rats. Two-way factorial ANOVA showed an interaction between the effects of doxazosin and insulin on systolic pressure and plasma glucose. The data show that after 20 weeks of doxazosin treatment, albuminuria was reduced by 80%; however, this treatment had no significant effect on mesangial expansion or progression to glomerulosclerosis. Conversely, good glycemic control prevented all three of the preceding sequelae.

Key Words: diabetic nephropathy • blood pressure • adrenergic alpha-antagonists • antihypertensive therapy • albuminuria • rats

This article has been cited by other articles:

				J. A. Joles and H. A. Koomans Causes and Consequences of Increased Sympathetic Activity in Renal Disease Hypertension, April 1, 2004; 43(4): 699 - 706. [Abstract] [Full Text] [PDF]

				H. A. Koomans, P. J. Blankestijn, and J. A. Joles Sympathetic Hyperactivity in Chronic Renal Failure: A Wake-up Call J. Am. Soc. Nephrol., March 1, 2004; 15(3): 524 - 537. [Abstract] [Full Text] [PDF]